Form 8-K - Current report:
SEC Accession No. 0001437749-25-005255
Filing Date
2025-02-26
Accepted
2025-02-26 17:04:17
Documents
24
Period of Report
2025-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20250225_8k.htm   iXBRL 8-K 35305
2 EXHIBIT 4.1 ex_782363.htm EX-4.1 103862
3 EXHIBIT 4.2 ex_782364.htm EX-4.2 109431
4 EXHIBIT 5.1 ex_782903.htm EX-5.1 13803
5 EXHIBIT 10.1 ex_782365.htm EX-10.1 239628
6 EXHIBIT 10.2 ex_782381.htm EX-10.2 100541
7 EXHIBIT 99.1 ex_782382.htm EX-99.1 12168
12 a01.jpg GRAPHIC 10221
13 af01.jpg GRAPHIC 6458
14 af02.jpg GRAPHIC 12150
15 mbrx20250225_8kimg001.jpg GRAPHIC 4610
  Complete submission text file 0001437749-25-005255.txt   948050

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20250225.xsd EX-101.SCH 3409
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20250225_def.xml EX-101.DEF 11424
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20250225_lab.xml EX-101.LAB 15310
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20250225_pre.xml EX-101.PRE 11584
26 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20250225_8k_htm.xml XML 2834
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 25671197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)